Wendong Yu

1.8k total citations
41 papers, 1.3k citations indexed

About

Wendong Yu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wendong Yu has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wendong Yu's work include Sarcoma Diagnosis and Treatment (6 papers), Mass Spectrometry Techniques and Applications (5 papers) and Oral and Maxillofacial Pathology (4 papers). Wendong Yu is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Mass Spectrometry Techniques and Applications (5 papers) and Oral and Maxillofacial Pathology (4 papers). Wendong Yu collaborates with scholars based in United States, China and Netherlands. Wendong Yu's co-authors include Michael Ittmann, Jialing Zhang, Lívia S. Eberlin, Jianghua Wang, Yi Cai, Andrew P. Rice, James Suliburk, John Q. Lin, Chengxi Ren and David M. Spencer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Wendong Yu

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendong Yu United States 20 690 387 229 174 170 41 1.3k
Monika Pietrowska Poland 29 1.8k 2.6× 330 0.9× 200 0.9× 883 5.1× 243 1.4× 96 2.3k
Shifang Ren China 19 759 1.1× 283 0.7× 58 0.3× 78 0.4× 137 0.8× 59 1.2k
Günther Ernst Germany 26 955 1.4× 607 1.6× 109 0.5× 186 1.1× 202 1.2× 51 1.7k
Clizia Chinello Italy 25 1.1k 1.7× 545 1.4× 266 1.2× 356 2.0× 126 0.7× 70 1.8k
Rita Casadonte Germany 19 887 1.3× 853 2.2× 70 0.3× 76 0.4× 98 0.6× 46 1.4k
Rossitza Lazova United States 28 886 1.3× 95 0.2× 193 0.8× 243 1.4× 760 4.5× 91 2.3k
Mayank Saraswat Finland 18 826 1.2× 129 0.3× 87 0.4× 249 1.4× 142 0.8× 59 1.2k
Thomas Flad Germany 16 511 0.7× 217 0.6× 70 0.3× 85 0.5× 221 1.3× 25 1.0k
Michael H. A. Roehrl United States 21 938 1.4× 154 0.4× 199 0.9× 283 1.6× 424 2.5× 85 1.9k
Anna G. Sorace United States 26 385 0.6× 195 0.5× 147 0.6× 202 1.2× 317 1.9× 98 1.8k

Countries citing papers authored by Wendong Yu

Since Specialization
Citations

This map shows the geographic impact of Wendong Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendong Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendong Yu more than expected).

Fields of papers citing papers by Wendong Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendong Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendong Yu. The network helps show where Wendong Yu may publish in the future.

Co-authorship network of co-authors of Wendong Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wendong Yu. A scholar is included among the top collaborators of Wendong Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendong Yu. Wendong Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meis, Jeanne M., et al.. (2025). NUT-rearranged sarcoma. Seminars in Diagnostic Pathology. 42(5). 150941–150941. 1 indexed citations
3.
Yu, Wendong, Qiong Gan, & Yun Yun Gong. (2023). The Yokohama System for Reporting Breast Cytopathology. 0(0). 0–0. 1 indexed citations
4.
Wakely, Paul E., et al.. (2023). Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review. Histopathology. 83(5). 712–721. 7 indexed citations
5.
Dehner, Carina, Jorge Torres‐Mora, Sounak Gupta, et al.. (2023). Sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases. Modern Pathology. 37(2). 100400–100400. 7 indexed citations
6.
Jang, Hee-Jin, Hyun‐Sung Lee, Wendong Yu, et al.. (2022). Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment. Cancer Research. 82(14). 2593–2609. 9 indexed citations
7.
King, Mary Etta, Jialing Zhang, John Q. Lin, et al.. (2021). Rapid diagnosis and tumor margin assessment during pancreatic cancer surgery with the MasSpec Pen technology. Proceedings of the National Academy of Sciences. 118(28). 50 indexed citations
8.
Burke, Thomas M., Harshal Abhyankar, Brooks Scull, et al.. (2020). Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH. Blood. 137(13). 1777–1791. 28 indexed citations
9.
Zhang, Jialing, et al.. (2019). Mass Spectrometry Imaging Enables Discrimination of Renal Oncocytoma from Renal Cell Cancer Subtypes and Normal Kidney Tissues. Cancer Research. 80(4). 689–698. 45 indexed citations
10.
DeHoog, Rachel J., Jialing Zhang, Elizabeth Alore, et al.. (2019). Preoperative metabolic classification of thyroid nodules using mass spectrometry imaging of fine-needle aspiration biopsies. Proceedings of the National Academy of Sciences. 116(43). 21401–21408. 40 indexed citations
11.
Piyarathna, Danthasinghe Waduge Badrajee, James M. Arnold, Stacy M. Lloyd, et al.. (2019). ERR1- and PGC1α-associated mitochondrial alterations correlate with pan-cancer disparity in African Americans. Journal of Clinical Investigation. 129(6). 2351–2356. 24 indexed citations
12.
Xu, Ya, Ting Zhou, Wendong Yu, & Neda Zarrin‐Khameh. (2018). Fine‐needle aspiration of alveolar soft part sarcoma: Histologic correlation and aberrant CD68 expression. Diagnostic Cytopathology. 47(2). 114–120. 2 indexed citations
13.
Zhang, Jialing, John Q. Lin, Jonathan H. Young, et al.. (2017). Nondestructive tissue analysis for ex vivo and in vivo cancer diagnosis using a handheld mass spectrometry system. Science Translational Medicine. 9(406). 300 indexed citations
14.
Zhang, Jialing, Wendong Yu, Seung Woo Ryu, et al.. (2016). Cardiolipins Are Biomarkers of Mitochondria-Rich Thyroid Oncocytic Tumors. Cancer Research. 76(22). 6588–6597. 65 indexed citations
15.
Feng, Shu, Longjiang Shao, Wendong Yu, Paul R. Gavine, & Michael Ittmann. (2012). Targeting Fibroblast Growth Factor Receptor Signaling Inhibits Prostate Cancer Progression. Clinical Cancer Research. 18(14). 3880–3888. 40 indexed citations
16.
Ramakrishnan, Rajesh, Wendong Yu, & Andrew P. Rice. (2011). Limited redundancy in genes regulated by Cyclin T2 and Cyclin T1. BMC Research Notes. 4(1). 260–260. 17 indexed citations
17.
Wang, Jianghua, Yi Cai, Wendong Yu, et al.. (2008). Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts. Cancer Research. 68(20). 8516–8524. 130 indexed citations
18.
Yu, Wendong, et al.. (2008). Cyclin T1-Dependent Genes in Activated CD4+ T and Macrophage Cell Lines Appear Enriched in HIV-1 Co-Factors. PLoS ONE. 3(9). e3146–e3146. 31 indexed citations
19.
Wang, Qing, Song Li, Wendong Yu, et al.. (2006). Cytoskeletal reorganization and repolarization of hepatocarcinoma cells in APA microcapsule to mimic native tumor characteristics. Hepatology Research. 35(2). 96–103. 19 indexed citations
20.
Haaland, Richard E., Wendong Yu, & Andrew P. Rice. (2004). Identification of LKLF-regulated genes in quiescent CD4 T lymphocytes. Molecular Immunology. 42(5). 627–641. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026